Floatz logo

PROPRANOLOL

Immunologic Factors

Tianjin Medical University General HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

23 Active assets in the Immunologic Factors cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Indapta Therapeutics, INC.
Phase 2BB
Fludarabine
Indapta Therapeutics, INC.
Phase 2BB
LIDOCAINE
Ciusss de L'Est de l'Île de Montréal
Phase 4BB
Strimvelis
Fondazione Telethon
Phase 4B
Evomela
Washington University School of Medicine
Phase 2B

View all 38 →

Same molecule, other indications

PROPRANOLOL is also rated in:

migraine disorderDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varices with bleedingDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →